Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study

BACKGROUND: Gadobutrol is a gadolinium-based contrast agent, uniquely formulated at 1.0 mmol/ml. Although there is extensive safety evidence on the use of gadobutrol in adults, few studies have addressed the safety and tolerability of gadobutrol in pediatric patients. OBJECTIVE: This subanalysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Glutig, Katja, Bhargava, Ravi, Hahn, Gabriele, Hirsch, Wolfgang, Kunze, Christian, Mentzel, Hans-Joachim, Schaefer, Jürgen F., Willinek, Winfried, Palkowitsch, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943967/
https://www.ncbi.nlm.nih.gov/pubmed/27041276
http://dx.doi.org/10.1007/s00247-016-3599-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943967/
https://www.ncbi.nlm.nih.gov/pubmed/27041276
http://dx.doi.org/10.1007/s00247-016-3599-6

Ejemplares similares